D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AVDL holding history
Avadel Pharmaceuticals PLC in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −132,459−100.0% | Sold out | Holders |
| Q4 2025 | 132,459 | $2.85M | <0.1% | −237,170−64.2% | Reduced | Holders |
| Q3 2025 | 369,629 | $5.64M | <0.1% | −67,926−15.5% | Reduced | Holders |
| Q2 2025 | 437,555 | $3.87M | <0.1% | −57,123−11.5% | Reduced | Holders |
| Q1 2025 | 494,678 | $3.87M | <0.1% | +185,020+59.7% | Added | Holders |
| Q4 2024 | 309,658 | $3.25M | <0.1% | +183,496+145.4% | Added | Holders |
| Q3 2024 | 126,162 | $1.65M | <0.1% | +91,290+261.8% | Added | Holders |
| Q2 2024 | 34,872 | $490.3K | <0.1% | −47,237−57.5% | Reduced | Holders |
| Q1 2024 | 82,109 | $1.39M | <0.1% | −114,445−58.2% | Reduced | Holders |
| Q4 2023 | 196,554 | $2.78M | <0.1% | −352,816−64.2% | Reduced | Holders |
| Q3 2023 | 549,370 | $5.66M | <0.1% | −216,466−28.3% | Reduced | Holders |
| Q2 2023 | 765,836 | $12.6M | <0.1% | +454,546+146.0% | Added | Holders |
| Q1 2023 | 311,290 | $2.85M | <0.1% | −32,465−9.4% | Reduced | Holders |
| Q4 2022 | 343,755 | $2.46M | <0.1% | −8,359−2.4% | Reduced | Holders |
| Q3 2022 | 352,114 | $1.76M | <0.1% | +338,682+2,521.5% | Added | Holders |
| Q2 2022 | 13,432 | $33.0K | <0.1% | +13,432 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −33,041−100.0% | Sold out | Holders |
| Q3 2021 | 33,041 | $324.0K | <0.1% | +19,405+142.3% | Added | Holders |
| Q2 2021 | 13,636 | $92.0K | <0.1% | +13,636 | New | Holders |